Global Microbiome Sequencing Services Market Report 2018-2023 - Rise in Demand for NGS Services - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Nov 29, 2018--The “Global Microbiome Sequencing Services Market - Segmented by Technology Type, Application, and End User - Growth, Trends, and Forecast (2018 - 2023)” report has been added to ResearchAndMarkets.com’s offering.The global microbiome sequencing services market is expected to register a CAGR of 18% during the forecast period 2018-2023. North America dominates the market due to a surge in technological advancement in next-generation sequencing (NGS) projects in the region.
Huge Investment in Microbiome ResearchThe sequencing of metagenome offers a novel method in diagnosing and treating a wide range of chronic diseases, such as oncology, etc. The metagenome differs from person to person significantly, which is key to its diagnostic potential, due to which the government is investing a large number of funds for microbiome sequencing projects.In 2007, the US National Institutes of Health (NIH) funded USD 140 million to the Human Microbiome Project, which examines all the microorganisms in the human body. In 2008, the European Commission financed USD 29 million for Metagenomics of the Human Intestinal Tract project (MetaHIT).The Wall Street Journal in 2016, reported that from 2011 to 2015, venture funding in microbiome firms climbed by 458.5% to USD114.5 million. About USD 616.9 million was raised for microbiome companies in 2016, which is more than all of the venture investment in the microbiome space between 2011 to 2015 period.Also, rising demand for NGS, surge in genomic research, and widening application area of microbiome sequencing, and a decline in the cost of sequencing are the major factors driving the growth of the market.
Lack of Skilled Technicians for NGS Data AnalysisLack of technicians in the interpretation of sequencing data is the major factor restricting the growth of the microbiome sequencing services market. Microbiome sequencing generates a huge amount of data, which needs to be interpreted using advanced software. The lack of awareness and knowledge of advanced tools of data analysis among physicians and scientists is the major factor restricting the growth of the global microbiome sequencing services market.Further, government regulations and ethical & legal issues related to NGS are the also restraining the growth of the microbiome sequencing services market.
North America to Dominate the Microbiome Sequencing Services MarketThe microbiome sequencing services market is segmented by technology type, application, end user, and geography. By geography, it is segmented into North America, Europe, Asia-Pacific, Middle East & Africa, and South America.North America dominates the microbiome sequencing services market, owing to factors, such as government support through funds for genomics research, consistent developments in sequencing technologies, and ease in availability of commercial solutions for NGS data analysis.Asia-Pacific is also expected to grow tremendously during the forecast period, owing to growing number of research studies on cancer and inherited rare diseases, and rising demand for next-generation sequencing for diagnosis and therapeutic applications.
Key Topics Covered
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario of Microbiome Sequencing Services
5.2 Porter’s Five Forces Analysis
6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Huge Investment in Microbiome Research
6.1.2 Rise in Demand for NGS Services
6.1.3 Decline in Cost of NGS Sequencing
6.1.4 Surge in Genomic Research and Widening Application Area of Microbiome Sequencing
6.2 Market Restraints
6.2.1 Ethical and Legal Issues Related to Genome Sequencing
6.2.2 Lack of Skilled Technicians for NGS Data Analysis
6.4 Key Challenges
7. Microbiome Sequencing Services Market Segmentation
7.1 By Technology
7.1.1 Sequencing by Litigation (SBL)
7.1.2 Sequencing by Synthesis (SBS)
7.1.3 Short Gun Sequencing
7.1.4 Targeted Gene Sequencing
7.1.5 RNA Sequencing
7.2 By Application
7.2.1 Gastro-Intestinal Diseases
7.2.2 Infectious Diseases
7.2.3 CNS Diseases
7.3 By End User
7.3.1 Research and Academic Institutes
7.3.2 Pharmaceutical and Biotechnology Companies
7.4 By Geography
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations and Partnerships
8.3 New Products Launches
9. Microbiome Sequencing Services Market Key Players
9.1 Baseclear B.V.
9.2 Clinical Microbiomics A/S
9.3 Merieux Nutrisciences Corporations
9.5 Microbiome Insights Inc.
9.6 Microbiome Therapeutics, LLC.
9.7 MR DNA
9.8 Second Genome
9.9 Ubiome, Inc.
9.10 Zymo Research Corp.
List Not Exhaustive
10. Future of the Market
For more information about this report visit https://www.researchandmarkets.com/research/pj2kjf/global_microbiome?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20181129005356/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 11/29/2018 07:37 AM/DISC: 11/29/2018 07:38 AM